Also known as Ipam, Ipamorelin Acetate, IPAM, NNC-26-0161 Ipamorelin is similar to growth hormone releasing peptide, notably GHRP-6 and GHRP-2. It shares similar characteristics with GHRP2 although it doesn’t induce hunger, and it lacks ghrelin’s lipogenic properties. It can act in synergy with Growth Hormone Releasing Hormone, or with Sermorelin and Modified GRF 1-29. Ipam also shares close similarities with GHRP-6 although it lacks the side effects that accompany GHRP-6.
IPAMORELIN side effects
IPAMORELIN has few if any side effects such as redness or itching at site of injection and some increase flushing, headaches and flushing which should be accounted for during trial. There are no known health risks associated with IPAMORELIN injections, especially when compared to traditional hormone-based metabolic, strengthening and growth treatments when compared side by side in animal studies.
The recommended dosage for IPAMORELIN is 100-200mcg daily, intramuscularly per injection at animal trial. Injection should be given on an empty stomach, thirty to sixty minutes before feed. Dosage should be continued for an eight-to-ten-week cycle, depending on required results.
The products we sell are to be used for laboratory research only and are not to be used for any other purposes. You must be 18 years or older to purchase from this store. You must be qualified and trained to work with the materials purchased from us.
Products from NG Peptides are for research purposes only and are not to be used for any other purpose including but not limited to; therapeutic, medical, veterinary, livestock or diagnostic purposes.